Study targets stroke prevention in children with sickle cell anemia

Oct 28, 2009

St. Jude Children's Research Hospital investigators were recently awarded a $23 million federal grant to launch a national study of the drug hydroxyurea to prevent first strokes in children and adolescents with sickle cell anemia (SCA).

The effort will be the fifth at St. Jude involving hydroxyurea to treat children with SCA. The focus will be on SCA patients who have not suffered strokes but have been identified as high risk for the complication by transcranial Doppler ultrasound (TCD) screening. The five-year study is expected to include a total of 26 medical centers and about 140 patients.

"Our goal with this study is to prevent brain complications in with sickle cell disease," explained Russell Ware, M.D., Ph.D., principal investigator for the study, which is funded by the National Heart, Lung, and Blood Institute. Ware chairs the St. Jude Department of Hematology and holds the Lemuel Diggs Endowed Chair in Sickle Cell Disease.

SCA is an inherited . In the U.S., it is diagnosed most frequently in African American individuals. The sickled they produce can disrupt circulation and cause pain, strokes and other debilitating and sometimes deadly complications.

The new study is called TWiTCH, short for TCD With Transfusions Changing to Hydroxyurea. Patients will be randomly assigned to either continue a standard therapy of monthly blood transfusions and chelation to remove the resulting iron buildup or to receive a daily dose of and monthly phlebotomy to remove excess iron. The goal is to compare the two treatments, including their ability to prevent a first .

Source: St. Jude Children's Research Hospital

Explore further: Scientists generate first human stomach tissue in lab with stem cells

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Heart's own immune cells can help it heal

55 minutes ago

(Medical Xpress)—The heart holds its own pool of immune cells capable of helping it heal after injury, according to new research in mice at Washington University School of Medicine in St. Louis.

Making lab-grown tissues stronger

1 hour ago

Lab-grown tissues could one day provide new treatments for injuries and damage to the joints, including articular cartilage, tendons and ligaments.

The 'ultimate' stem cell

2 hours ago

In the earliest moments of a mammal's life, the developing ball of cells formed shortly after fertilisation 'does as mother says' – it follows a course that has been pre-programmed in the egg by the mother. ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.